Put companies on watchlist
Obotritia Capital KGaA
ISIN: DE000A1616U7
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Obotritia Capital KGaA · ISIN: DE000A1616U7 · EQS - Company News (1 News)
Country: Germany · Primary market: Germany · EQS NID: 1162388
21 January 2021 05:40PM

Obotritia Beta Invest GmbH intends placement of around 10% of the shares of Compleo Charging Solutions AG with institutional investors


DGAP-News: Obotritia Capital KGaA / Key word(s): Miscellaneous
Obotritia Beta Invest GmbH intends placement of around 10% of the shares of Compleo Charging Solutions AG with institutional investors

21.01.2021 / 17:40
The issuer is solely responsible for the content of this announcement.


Obotritia Beta Invest GmbH intends placement of around 10% of the shares of Compleo Charging Solutions AG with institutional investors

Potsdam, 21 January 2021

Obotritia Beta Invest GmbH ("Obotritia Beta"), a subsidiary of Obotritia Capital KGaA, intends to place ("Placement") approximately 10% of the shares of Compleo Charging Solutions AG ("Company") with institutional investors in an accelerated bookbuilding procedure ("Accelerated Bookbuilding"). COMMERZBANK Aktiengesellschaft ("COMMERZBANK") shall act as bookrunner and ODDO BHF Aktiengesellschaft ("ODDO BHF") shall act as co-bookrunner in connection with the Placement. The Accelerated Bookbuilding is scheduled to start today and is expected to be completed on 22 January 2021. Settlement of the placed shares is scheduled for 26 January 2021.

Holding 20.25% of the share capital, Obotritia Beta is currently the Company's largest shareholder. Obotritia Beta had acquired this shareholding on 14 December 2020 from its subsidiary, Fontus Invest GmbH ("Fontus"), and assumed through this transaction Fontus' lock-up obligation towards the bookrunners resulting from the Company's initial public offering in October 2020. For purposes of the Placement, the bookrunners have partially waived Obotritia Beta's lock-up obligation. However, regarding the remaining shareholding of Obotritia Beta in the Company, the lock-up obligation remains in place.

During Obotritia Beta's investment to date (via Fontus), the Company has developed into a leading provider of charging solutions for electric vehicles. This led to a successful initial public offering of the Company on the regulated market of the Frankfurt Stock Exchange (Prime Standard) in October 2020.



Contact:
Obotritia Capital KGaA
Dr. Marcus Kiefer
CFO
August-Bebel-Str. 68
14482 Potsdam
Phone: +49 (0) 331 740 076 521
Fax: +49 (0) 331 740 076 520
E-Mail: mk@obocap.com


21.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Obotritia Capital KGaA
August-Bebel-Str. 68
14482 Potsdam
Germany
Phone: +49 (0) 331 74 00 76 -521
Fax: +49 (0) 331 74 00 76 -520
E-mail: info@obocap.com
Internet: www.obocap.com
ISIN: DE000A1616U7
WKN: A1616U
Listed: Regulated Unofficial Market in Frankfurt
EQS News ID: 1162388

 
End of News DGAP News Service

1162388  21.01.2021 

fncls.ssp?fn=show_t_gif&application_id=1162388&application_name=news&site_id=boersengefluester_html

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.